<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Clinical Thyroidology for the Public &#8211; American Thyroid Association</title>
	<atom:link href="https://www.thyroid.org/category/clinical-thyroidology-for-the-public/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.thyroid.org</link>
	<description>Thyroid Cancer, Hyperthyroid, Hypothyroid, Thyroiditis, Thyroid Clinical Trials, Tyroid Patient Health Information</description>
	<lastBuildDate>Mon, 13 Apr 2026 00:12:51 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>
	<item>
		<title>Hypothyroidism and risks of bariatric surgery &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-april-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Mon, 13 Apr 2026 00:12:00 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=78061</guid>

					<description><![CDATA[<p>Bariatric surgery is generally safe, but problems after the procedure can occur. It is not clear if patients with hypothyroidism have higher chances of complications after bariatric surgery. This study was done to find out the risks of bariatric surgery in patients with hypothyroidism. </p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-april-2026/">Hypothyroidism and risks of bariatric surgery &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>Bariatric surgery is generally safe, but problems after the procedure can occur. It is not clear if patients with hypothyroidism have higher chances of complications after bariatric surgery. This study was done to find out the risks of bariatric surgery in patients with hypothyroidism. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/april-2026/vol-19-issue-4-p-3-4/"><strong> Read More&#8230;</strong></a></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-april-2026/">Hypothyroidism and risks of bariatric surgery &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>2025 ATA Differentiated Thyroid Cancer Guidelines: Completion Thyroidectomy- Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-march-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Mon, 16 Mar 2026 12:55:21 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=78011</guid>

					<description><![CDATA[<p>A significant change in the 2025 thyroid cancer guidelines is an increase in the recommendation of lobectomy. Prior guidelines indicate that completion thyroidectomy is considered in up to 20% of patients with a lobectomy and cancer >2 and ≤4 cm. This paper summarizes the changes in recommendations for completion thyroidectomy in the 2025 ATA differentiated thyroid cancer guidelines. </p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-march-2026/">2025 ATA Differentiated Thyroid Cancer Guidelines: Completion Thyroidectomy- Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>A significant change in the 2025 thyroid cancer guidelines is an increase in the recommendation of lobectomy. Prior guidelines indicate that completion thyroidectomy is considered in up to 20% of patients with a lobectomy and cancer >2 and ≤4 cm. This paper summarizes the changes in recommendations for completion thyroidectomy in the 2025 ATA differentiated thyroid cancer guidelines.  <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/march-2026/vol-19-issue-2-p-9-10/"><strong> Read More&#8230;</strong></a></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-march-2026/">2025 ATA Differentiated Thyroid Cancer Guidelines: Completion Thyroidectomy- Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Development of a model to predict who will need to take a thyroid hormone pill after partial removal of the thyroid gland &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-february-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Wed, 18 Feb 2026 00:52:19 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<category><![CDATA[Thyroid Surgery]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77799</guid>

					<description><![CDATA[<p>The study authors reviewed the medical records for all patients who underwent partial thyroidectomy at their institution between 2013 and 2020. They identified 425 patients who met study criteria. The authors then identified which of these patients were prescribed levothyroxine after surgery.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-february-2026/">Development of a model to predict who will need to take a thyroid hormone pill after partial removal of the thyroid gland &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>When all of the thyroid is removed by surgery, patients will require a thyroid pill after surgery. When only part of the thyroid gland is removed during surgery (partial thyroidectomy or thyroid lobectomy), the thyroid tissue left behind might produce enough thyroid hormone to meet the body’s needs. The goal of this study was to develop a model to help predict which people will need to take a thyroid hormone pill after partial thyroidectomy. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/february-2026/vol-19-issue-2-p-3-4/"><strong> Read More&#8230;</strong></a></p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-february-2026/">Development of a model to predict who will need to take a thyroid hormone pill after partial removal of the thyroid gland &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Long-term safety of treatment options for hyperthyroidism: which is the best? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-january-2026/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Tue, 20 Jan 2026 00:16:35 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=77659</guid>

					<description><![CDATA[<p>There are 3 treatment options for hyperthyroidism – antithyroid drugs, radioactive iodine therapy and thyroid surgery. There are various factors that go into deciding which treatment option to consider, including the underlying cause for hyperthyroidism, side effects of treatment and patient preferences. This study aimed to assess the long-term safety of each of the three options of treatment for hyperthyroidism.</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-january-2026/">Long-term safety of treatment options for hyperthyroidism: which is the best? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>There are 3 treatment options for hyperthyroidism – antithyroid drugs, radioactive iodine therapy and thyroid surgery. There are various factors that go into deciding which treatment option to consider, including the underlying cause for hyperthyroidism, side effects of treatment and patient preferences. This study aimed to assess the long-term safety of each of the three options of treatment for hyperthyroidism. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/january-2026/vol-19-issue-1-p-3-4/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-january-2026/">Long-term safety of treatment options for hyperthyroidism: which is the best? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Do statins affect the onset of thyroid eye disease in patients with Graves’ disease? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-november-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Fri, 14 Nov 2025 00:13:33 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<category><![CDATA[Graves' Disease]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=76991</guid>

					<description><![CDATA[<p>From Clinical Thyroidology® for the Public: Thyroid eye disease (TED) develops in 25 to 40%...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-november-2025/">Do statins affect the onset of thyroid eye disease in patients with Graves’ disease? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public: </em>Thyroid eye disease (TED) develops in 25 to 40% of patients with Graves’ disease, particularly during the first 1 to 2 years following the onset of hyperthyroidism. Statins are widely prescribed drugs that lower cholesterol that also have anti-inflammatory effects and may be able to interfere with the immune response. This study aimed to determine whether starting statins early or whether the start is delayed affects the risk of developing TED in a large nationwide group. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/november-2025/vol-18-issue-11-p-5-6/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-november-2025/">Do statins affect the onset of thyroid eye disease in patients with Graves’ disease? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Who really needs radioactive iodine therapy for thyroid cancer? Insights from the IoN trial &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-october-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Sun, 19 Oct 2025 23:48:53 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=76862</guid>

					<description><![CDATA[<p>From Clinical Thyroidology® for the Public: Radioactive iodine works as a “magic bullet” as it...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-october-2025/">Who really needs radioactive iodine therapy for thyroid cancer? Insights from the IoN trial &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public:</em> Radioactive iodine works as a “magic bullet” as it is taken up and stored only by thyroid cells, both normal and cancerous, and destroys them. While in the past most patients were treated with radioactive iodine therapy, the more recent practice is to be selective when considering who would benefit from this treatment. The IoN trial was designed to assess whether observation provided similar outcomes compared to administering radioactive iodine therapy in patients with thyroid cancer with a low-to-intermediate risk of recurrence. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/october-2025/vol-18-issue-10-p-9-10/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-october-2025/">Who really needs radioactive iodine therapy for thyroid cancer? Insights from the IoN trial &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>How long do pregnancy-related thyroid problems last? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-august-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Wed, 13 Aug 2025 12:41:01 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Friends of the ATA]]></category>
		<category><![CDATA[Thyroid Disease and Pregnancy]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=76262</guid>

					<description><![CDATA[<p>From Clinical Thyroidology® for the Public: Disorders of the thyroid, including autoimmune disorders, can develop...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-august-2025/">How long do pregnancy-related thyroid problems last? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public:</em>  Disorders of the thyroid, including autoimmune disorders, can develop during pregnancy. It is recognized that test results of thyroid function vary in pregnancy based on the pregnancy trimester. This study aims to analyze thyroid function changes in different trimesters of pregnancy and compare these changes with pregnancy outcomes.  <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/august-2025/vol-18-issue-8-p-3-4/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-august-2025/">How long do pregnancy-related thyroid problems last? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Does radioactive iodine therapy change outcomes in low-to-intermediate risk papillary thyroid cancers? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-june-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Fri, 20 Jun 2025 16:14:38 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=75324</guid>

					<description><![CDATA[<p>From Clinical Thyroidology® for the Public: Papillary thyroid cancer has an excellent prognosis. Since the...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-june-2025/">Does radioactive iodine therapy change outcomes in low-to-intermediate risk papillary thyroid cancers? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public:</em> Papillary thyroid cancer has an excellent prognosis. Since the vast majority of patients with papillary thyroid cancer do not die of their cancer, it can be difficult to evaluate the effect of treatment on overall survival. This study was performed to evaluate whether the use of radioactive iodine therapy can improve survival in patients with low-to-intermediate risk papillary thyroid cancer that have spread of the cancer to lymph nodes in the neck at the time of surgery. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/june-2025/vol-18-issue-p-5-6/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-june-2025/">Does radioactive iodine therapy change outcomes in low-to-intermediate risk papillary thyroid cancers? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Does radioactive iodine therapy for Graves’ disease increase the risk for thyroid cancer? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-may-2025/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Mon, 12 May 2025 01:30:17 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=74636</guid>

					<description><![CDATA[<p>From Clinical Thyroidology® for the Public: While studies have demonstrated a link between radioactive iodine...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-may-2025/">Does radioactive iodine therapy for Graves’ disease increase the risk for thyroid cancer? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public:</em> While studies have demonstrated a link between radioactive iodine therapy treatment for thyroid cancer and a slight increased long-term risk for other cancers in the body, a much lower dose of radioactive iodine therapy is used in the treatment of Graves’ disease. A few studies have looked at the association between radioactive iodine therapy for hyperthyroidism and long-term cancer risk and the results are variable. This study specifically reviews the risk of identifying thyroid cancer in patients with Graves’ disease who underwent thyroid surgery and compares the data between patients who previously received radioactive iodine therapy and those who did not. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/may-2025/vol-18-issue-5-p-5-6/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/clinical-thyroidology-public-highlighted-article-may-2025/">Does radioactive iodine therapy for Graves’ disease increase the risk for thyroid cancer? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Thyroid surgery and chronic kidney disease: Is there a link? &#8211; Clinical Thyroidology® for the Public</title>
		<link>https://www.thyroid.org/thyroid-clinical-thyroidology/</link>
		
		<dc:creator><![CDATA[ATA]]></dc:creator>
		<pubDate>Fri, 11 Apr 2025 11:29:14 +0000</pubDate>
				<category><![CDATA[Clinical Thyroidology for the Public]]></category>
		<category><![CDATA[Featured]]></category>
		<guid isPermaLink="false">https://www.thyroid.org/?p=74046</guid>

					<description><![CDATA[<p>From Clinical Thyroidology® for the Public: A potential complication of thyroid surgery is hypoparathyroidism caused...</p>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/thyroid-clinical-thyroidology/">Thyroid surgery and chronic kidney disease: Is there a link? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><em>From Clinical Thyroidology<sup>®</sup> for the Public:</em> A potential complication of thyroid surgery is hypoparathyroidism caused by damage to the parathyroid glands causing hypocalcemia (low calcium levels). Post-surgical permanent hypoparathyroidism is much more serious and can lead to chronic kidney disease (CKD). This study was done to understand the risk of developing hypoparathyroidism and CKD after total thyroidectomy. <a href="https://www.thyroid.org/patient-thyroid-information/ct-for-patients/april-2025/vol-18-issue-4-p-13-14/"><strong> Read More&#8230;</strong></a></p>
<p><em><strong>We welcome your feedback and suggestions. Let us know what you want to see in this publication.</strong></em></p>
<a class="nectar-button medium see-through-2 has-icon"  href="/patient-thyroid-information/ct-for-patients/3273-2/" data-color-override="#000" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>Feedback &amp; Suggestions</span><i class="fa fa-comment-o"></i></a>
<p>The post <a rel="nofollow" href="https://www.thyroid.org/thyroid-clinical-thyroidology/">Thyroid surgery and chronic kidney disease: Is there a link? &#8211; Clinical Thyroidology® for the Public</a> appeared first on <a rel="nofollow" href="https://www.thyroid.org">American Thyroid Association</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
